Aspirin and the Doctor’s Office

  • Steven M. RooneyEmail author
  • J. N. Campbell
Part of the SpringerBriefs in Molecular Science book series (BRIEFSMOLECULAR)


Dr. Bowen Eacritt Taylor attended medical school at the University of Nebraska and took part in the most advanced era to date of modern medicine. By the 1940s, gone were the hucksters that peddled patent medications that demeaned and vilified the doctor as a charlatan; now the AMA was an organization that had the power to lobby Washington and to protect its membership. It was a new time.


Heart Attack Coronary Thrombosis Scarlet Fever Medicine Cabinet Organic Chemistry Laboratory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Taylor T (2016) Personal communicationGoogle Scholar
  2. 2.
    McTavish J (2004) Pain and profits: the history of the headache and its remedies in America. Rutgers University, New BrunswickGoogle Scholar
  3. 3.
    Gabriel J (2014) Medical monopoly: intellectual property rights and the origins of the modern pharmaceutical industry. University of Chicago Press, Chicago, pp 198–199CrossRefGoogle Scholar
  4. 4.
    Li J (2014) Blockbuster drugs: the rise and decline of the pharmaceutical industry. Oxford Press, Oxford, pp 107–108Google Scholar
  5. 5.
    Craven L (1953) Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J 75:38–44Google Scholar
  6. 6.
    Craven L (1956) Prevention of coronary and cerebral thrombosis. Miss Valley Med J 78:213–215Google Scholar
  7. 7.
    Mann C, Plummer M (1991) The aspirin wars: money, medicine, and 100 years of rampant competition. Knopf, New YorkGoogle Scholar
  8. 8.
    Weiss H, Aledort L (1967) Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet 2:495–497CrossRefGoogle Scholar
  9. 9.
    Jeffreys D (2004) Aspirin: the remarkable story of a wonder drug. Bloomsbury, London, p 239Google Scholar
  10. 10.
    Roberts S (2016) Dr. Philip Majerus, who discerned aspirin’s heart benefits, dies at 79. New York TimesGoogle Scholar
  11. 11.
    Miner J, Hoffhines A (2007) The discovery of aspirin’s antithrombotic effects. TX Heart Inst J 34:184Google Scholar
  12. 12.
    Li J (2014) Blockbuster drugs: the rise and decline of the pharmaceutical industry. Oxford Press, Oxford, p 138Google Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.Independent ScholarIrvingUSA
  2. 2.Independent ScholarSpringUSA

Personalised recommendations